OLR1 and type 2 diabetes mellitus: Moreover, LOX-1 expression was not statistically significantly lower in the T2DM group compared to the disease-free groups (p > 0.05), but metformin administration significantly increased LOX-1 expression to levels higher than in the T2DM group (p < 0.05).